Studies on Fletcher trait and Fitzgerald trait

Hidehiko Saito

doi:10.1160/TH10-01-0058

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 104(05): 867-874
DOI: 10.1160/TH10-01-0058

Theme Issue Article

Schattauer GmbH

Studies on Fletcher trait and Fitzgerald trait

A rare chance to disclose body’s defense reactions against injury

Hidehiko Saito

¹Nagoya Central Hospital, Nagoya, Japan

› Author Affiliations

Abstract

Summary

The way by which contact of blood with foreign surface accelerates clotting has been elucidated from the discovery of four rare disorders of blood coagulation; Hageman trait, plasma thromboplastin antecedent (PTA) deficiency, Fletcher trait, and Fitzgerald trait. Interestingly, it was unexpectedly found that Fletcher factor is plasma prekallikrein and Fitzgerald factor is high-molecular-weight kininogen; components of the kinin-generating system, thus disclosing intimate relationships among clotting, fibrinolysis and kinin generation which may be viewed as body’s defense reactions against injury. This review mainly reflects our research on Fletcher trait and Fitzgerald trait during the 1970s in Cleveland.

Keywords

Contact factor - kinin system - fibrinolysis - Fletcher trait - Fitzgerald trait

Full Text

References

References
1 Margolis J. Glass surface and blood coagulation. Nature 1956; 178: 805-806.
2 Shafrir E, de Vries A. Studies on the clot-promoting activity of glass. J Clin Invest 1956; 35: 1183-1190.
3 Ratnoff OD, Colopy JE. A familiar hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955; 34: 602-613.
4 Margolis J. Activation of plasma by contact with glass: Evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958; 144: 1-22.
5 Armstrong D, Jepson JB, Keele CA. et al. Pain-producing substance in human inflammatory exudates and plasma. J Physiol 1957; 135: 350-370.
6 Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor. 1. Case report, coagulation studies, and physicochemical properties. Blood 1965; 26: 521-532.
7 Hathaway WE. Discovery of the Fletcher factor: 1963–1965. Ann Rep Hemophilia Thromb Res Soc 2007; 3-4.
8 Hathaway WE, Alsever J. The relation of ‘Fletcher Factor’ to Factors XI and XII. Br J Haematol 1970; 18: 161-169.
9 Saito H, Ratnoff OD, Marshall JS. et al. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. J Clin Invest 1973; 52: 850-861.
10 Saito H, Ratnoff OD, Donaldson VH. et al. Fletcher factor deficiency (Letter to the Editor). Blood 1972; 39: 745-747.
11 Ratnoff OD, Rsenblum JM. Role of Hageman factor in the initiation of clotting by glass. Evidence that glass frees Hageman factor from inhibition. Am J Med 1958; 25: 160-168.
12 Wuepper KD. Prekallikrein deficiency in man. J Exp Med. 1973; 138: 1345-1355.
13 Saito H., Ratnoff O.D., Donaldson V.H.. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma. Circ Res 1974; 34: 641-651.
14 Donaldson V.H., Saito H., Ratnoff O.D.. Defective esterase and kinin-forming activity in human Fletcher trait plasma; a fraction rich in kallikrein-like activity. Circ Res 1974; 34: 652-662.
15 Weiss AS, Gallin JI, Kaplan AP. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest 1974; 53: 622-633.
16 Saito H., Ratnoff O.D.. Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum. Nature (London) 1974; 248: 597-598.
17 Waldmann R., Abraham J.P., Rebuck J.W.. et al. Fitzgerald factor: a hitherto unrecognized coagulation factor. Lancet 1975; 01: 949-952.
18 Saito H., Ratnoff O.D., Waldmann R.. et al. Fitzgerald trait: Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis and generation of kinins and PE/Dil. J Clin Invest 1975; 55: 1082-1089.
19 Schiffman S, Lee P. Preparation, characterization, and activation of a highly purified Factor XI: Evidence that a hitherto unrecognized plasma activity participates in the interaction of Factors XI and XII. Br J Haematol 1974; 27: 101-114.
20 Schiffman S, Lee P, Waldmann R. Identity of contact activation co-factor with Fitzgerald factor. Thromb Res 1975; 06: 451-4.
21 Jacobsen S. Separation of two different substrates for plasma kinin-forming enzymes. Nature (Lond.) 1966; 210: 98-99.
22 Lacombe M-J, Varet B, Levy J-P. A hitherto undescribed plasma factor activity at the contact phase of blood coagulation (Flaujeac factor): Case report and coagulation studies. Blood 1975; 46: 761-768.
23 Wuepper KD, Miller D, Lacombe M. Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest 1975; 56: 1663-1672.
24 Colman RW, Bagdasarian A, Talamo RC. et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975; 56: 1650-1662.
25 Donaldson VH, Glueck HI, Miller A. et al. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J Lab Clin Med 1976; 87: 327-337.
26 Lutcher CL. Reid trait: A new expression of high molecular weight kininogen (HMW kininogen) deficiency. Clin Res 1976; 24: 47A.
27 Saito H.. Purification of HMW-kininogen (Fitzgerald factor) and the role of this agent in blood coagulation. J Clin Invest 1977; 60: 584-594.
28 Griffin JH. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci USA 1978; 75: 1998-2002.
29 Cochrane CG, Revak SD, Wuepper KD. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med 1973; 138: 1564-1583.
30 Mandel R, Colman RW, Kaplan A. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179-4183.
31 Donaldson V.H., Kleniewski J., Saito H.. et al. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect : Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest 1977; 60: 571-583.
32 Griffin J, Cochrane CG. Mechanisms for the involvement of high M. W. kininogen in surface dependent reaction of Hageman factor. Proc Natl Acad Sci USA 1976; 73: 2554-2558.
33 Wiggins RC, Bouma BN, Cochrane CG. et al. Role of high-molecular-weight-kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci USA 1977; 74: 4636-4640.
34 Saito H, Kojima T. Factor XII prekallikrein, and high molecular weight kininogen. In: Molecular Basis of Thrombosis and Hemostasis. Marcel Dekker, Inc.; 1995. pp. 269-285.
35 McMillin CR, Saito H, Ratnoff OD. et al. The secondary structure of human Hageman factor (Factor XII) and its alteration by activating agents. J Clin Invest 1974; 54: 1312-1322.
36 Fair BD, Saito H, Ratnoff OD. et al. Detection by fluorescence of structural changes accompanying the activation of Hageman Factor (Factor XII). Proc Soc Exp Biol Med 1977; 155: 199-202.
37 Samuel M, Pixley RA, Villanueva MA. et al. Human Factor XII (Hageman factor) autoactivation by dextran sulfate. J Biol Chem 1992; 267: 19691-19697.
38 Rebuck J, Waldmann R, Abraham J. et al. Importance of contact activated coagulation factors in inflammation. J Reticuloend Soc 1976; 20: 58A.
39 Hathaway WE, Wuepper KD, Weston WL. et al. Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med 1976; 60: 654-664.
40 Poon M-C, Moore MR, Castleberry RP. et al. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (Factor XII): Report of a case with observation on in vivo and in vitro leukocyte chemotaxis. Am J Hematol 1982; 12: 261-270.
41 Ratnoff OD. Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. In: Advances in Immunology. Vol 10. New York: Academic Press; 1969. pp. 145-227.
42 Fujikawa K, Chung DW, Hendrickson LE. et al. Amino acid sequence of human factor XIa blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25: 2417-2424.
43 Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately?. Blood 2009; 114: 2367-2374.
44 Alving BM, Hojima Y, Pisano JJ. et al. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fractions. New Eng J Med 1978; 299: 66-77.
45 Kishimoto TK, Viswanathan K, Ganguly T. et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. New Eng J Med 2008; 358: 2457-2467.
46 Saito H, Poon M.C., Vicic W., Goldsmith G.H., Menitove J.E.. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. J Lab Clin Med 1978; 92: 84-95.
47 Saito H, Goldsmith G, Waldmann R. Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in heath and disease, and in various animal plasmas. Blood 1976; 48: 941-947.
48 Schapira M, Silver LD, Scott CF. et al. Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. New Eng J Med 1983; 308: 1050-1053.
49 Blat Y, Seiffert D. A renaissance for the contact system in blood coagulation?. Throm Haemost 2008; 99: 457-460.
50 Shariat-Madar Z, Mahdi F, Schmaier AH. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 2002; 277: 17962-17969.
51 Smith SA, Mutch NJ, Baskar D. et al. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-908.
52 Kannemeier C, Shibamiya A, Nakazawa F. et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388-6393.
53 Maas C, Govers-Riemslag JWP, Bouma B. et al. Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118: 3208-3218.
54 Renne T, Pozgaiova M, Gruner S. et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281.
55 Merkulov S, Zhang W-M, Komar AA. et al. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 2008; 111: 1274-1281.